Phase I study of AR-42 and decitabine in acute myeloid leukemia

Liva, SG; Coss, CC; Wang, J; Blum, W; Klisovic, R; Bhatnagar, B; Walsh, K; Geyer, S; Zhao, QH; Garzon, R; Marcucci, G; Phelps, MA; Walker, AR

Walker, AR (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA.

LEUKEMIA & LYMPHOMA, 2020; 61 (6): 1484

Abstract

This phase I trial sought to determine a biologically safe and effective dose of AR-42, a novel histone deacetylase inhibitor, which would lead to a d......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索